Effect of protease inhibitors on experimental peptic ulceration.
D000818:Animals; D000863:Antacids / Q000627:therapeutic use; D002351:Carrageenan / Q000627:therapeutic use; D002482:Cellulose / Q000627:therapeutic use; D002606:Charcoal / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D007475:Ion Exchange Resins / Q000627:therapeutic use*; D010368:Pectins / Q000627:therapeutic use; D010434:Pepsin A / Q000037:antagonists & inhibitors*; D010437:Peptic Ulcer / Q000209:etiology / Q000517:prevention & control*; D011134:Polysaccharides / Q000627:therapeutic use*; D011480:Protease Inhibitors; D013431:Sulfates / Q000627:therapeutic use*
D000863:Antacids; D007475:Ion Exchange Resins; D011134:Polysaccharides; D011480:Protease Inhibitors; D013431:Sulfates; D002606:Charcoal; D010368:Pectins; D002351:Carrageenan; D002482:Cellulose; D010434:Pepsin A